Metabolic Changes in Synaptosomes in an Animal Model of Schizophrenia Revealed by 1H and 1H,13C NMR Spectroscopy
Open Access
- 23 February 2020
- journal article
- research article
- Published by MDPI AG in Metabolites
- Vol. 10 (2), 79
- https://doi.org/10.3390/metabo10020079
Abstract
Synaptosomes are isolated nerve terminals that contain synaptic components, including neurotransmitters, metabolites, adhesion/fusion proteins, and nerve terminal receptors. The essential role of synaptosomes in neurotransmission has stimulated keen interest in understanding both their proteomic and metabolic composition. Mass spectrometric (MS) quantification of synaptosomes has illuminated their proteomic composition, but the determination of the metabolic composition by MS has been met with limited success. In this study, we report a proof-of-concept application of one- and two-dimensional nuclear magnetic resonance (NMR) spectroscopy for analyzing the metabolic composition of synaptosomes. We utilize this approach to compare the metabolic composition synaptosomes from a wild-type rat with that from a newly generated genetic rat model (Disc1 svΔ2), which qualitatively recapitulates clinically observed early DISC1 truncations associated with schizophrenia. This study demonstrates the feasibility of using NMR spectroscopy to identify and quantify metabolites within synaptosomal fractions.Funding Information
- National Institutes of Health (T32 GM007507, P41 GM103399, P41 GM111135)
This publication has 55 references indexed in Scilit:
- Genetic relationship between five psychiatric disorders estimated from genome-wide SNPsNature Genetics, 2013
- The neurobiology of depression—revisiting the serotonin hypothesis. II. Genetic, epigenetic and clinical studies Philosophical Transactions B, 2013
- The 5-HT deficiency theory of depression: perspectives from a naturalistic 5-HT deficiency model, the tryptophan hydroxylase 2Arg439Hisknockin mousePhilosophical Transactions B, 2012
- From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for TreatmentNeuropsychopharmacology, 2011
- Interactions of human truncated DISC1 proteins: implications for schizophreniaTranslational Psychiatry, 2011
- Genetic overlap between autism, schizophrenia and bipolar disorderGenome Medicine, 2009
- Comparison of 1D and 2D NMR Spectroscopy for Metabolic ProfilingJournal of Proteome Research, 2007
- Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humansProceedings of the National Academy of Sciences of the United States of America, 2007
- Association of DISC1 with autism and Asperger syndromeMolecular Psychiatry, 2007
- DISC1 localizes to the centrosome by binding to kendrinBiochemical and Biophysical Research Communications, 2004